ReviewCureus2026
Mobile Health Interventions in Gestational Diabetes Mellitus and Pregnancy Outcomes: A Scoping Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus (GDM), one of the rising epidemics in pregnancies worldwide, is defined as glucose intolerance that is first recognised during pregnancy. GDM is associated with adverse maternal and fetal outcomes, including pre-eclampsia, caesarean delivery, and macrosomia. Mobile health (mHealth) interventions have emerged as promising tools for managing GDM, enabling remote monitoring, education, and communication. Hence, the present study was undertaken to map the nature of the use of mHealth interventions in GDM and report pregnancy outcomes based on the available literature. The scoping review was conducted following a systematic search for studies in PubMed, ScienceDirect, and Google Scholar databases in the last five years (2019-2024) that investigated an mHealth app intervention for mothers with GDM and reported maternal or fetal outcomes. Both randomised controlled trials (RCTs) and observational studies were included. A total of seven studies were included in this review, of which four were randomised trials and three were observational studies. The types of mHealth interventions varied widely, including mobile applications, SMS-based platforms, wearable devices, and teleconsultation systems. An RCT (China, 2019) reported that a nurse-guided smartphone app significantly improved glucose control and reduced weight gain in patients with GDM compared with usual care. Further, a study (Sweden, 2021) reported improved glycaemic control and compliance. Another trial (Slovenia, 2023) showed that a comprehensive telemedicine programme led to better postprandial glucose control and fewer caesarean deliveries. A Swiss trial (MySweetheart trial, 2024) combining app-based and telehealth coaching reduced gestational weight gain. The study revealed that app-based intervention such as mHealth showed potential to support glucose monitoring, weight management, improvement in pregnancy outcomes, and patient engagement in GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.